NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
NutriBand Inc.
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026
$6.00−0.22 (-3.54%)
Close on Oct 19, 2026
- Market cap
- $72.94M
- P/E (TTM)
- –
- Dividend yield
- –
NutriBand Inc. revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Pocono Pharmaceuticals [Member] | $2.04M | $2.14M | $1.92M | – | – | – | – | 100.0% | -4.8% |
| 4P Therapeutics [Member] | – | – | $165.03K | – | – | – | – | – | – |
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Sale of Goods [Member] | $2.04M | $2.14M | $1.92M | – | – | – | – | 100.0% | -4.8% |
| Services [Member] | – | – | $165.03K | – | – | – | – | – | – |
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| United States | $2.03M | $2.14M | $2.09M | $2.08M | $346.89K | $58.04K | $196.29K | 99.6% | -5.2% |
| Foreign [Member] | $7.63K | – | – | – | $86.60K | $61.32K | $49.00K | 0.4% | – |
From the segment and revenue-disaggregation notes of NutriBand's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.